$8.460
+1.160 (+13.71%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Contineum Therapeutics Inc (CTNM) Moving Averages Convergence Divergence (MACD) indicator is -1.67, suggesting CTNM is Strong sell.
Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 10.90, while Contineum Therapeutics Inc (CTNM) share price is $—, making it Sell.
Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 13.86, while Contineum Therapeutics Inc (CTNM) share price is $—, making it Sell.
Technical Analysis for CTNM
AI Technical CTNMAs of 2026-10-17, the technical board for Contineum Therapeutics Inc (CTNM) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $8.46 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 33.716, MACD stands at -1.674 (Sell), Stochastic %K stands at 19.939 (Buy), Stochastic %D stands at 12.323 and CCI stands at -75.618.
CTNM trades below the 60-day SMA (13.86) and below the 200-day SMA (13.59). Immediate resistance sits at Classic R1 13.07, then R2 17.03. Support sits at Classic S1 5.94, then S2 2.77.
Contineum Therapeutics Inc (CTNM) Support & Resistance Level
Contineum Therapeutics Inc (CTNM) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 33.716 |
| STOCHk_14_3_3 | 19.939 |
| STOCHd_14_3_3 | 12.323 |
| CCI_20 | -75.618 |
| AO_5_34 | -4.695 |
| MOM_10 | -4.190 |
| MACD_12_26_9 | -1.674 |
Contineum Therapeutics Inc (CTNM) Relative Strength Index (RSI_14) is 33.716, creating a Neutral signal.
Contineum Therapeutics Inc (CTNM) Stochastic %K is 19.939, creating a Buy signal.
Contineum Therapeutics Inc (CTNM) Stochastic %D is 12.323, creating a Buy signal.
Contineum Therapeutics Inc (CTNM) CCI_20 is -75.618, creating a Neutral signal.
Contineum Therapeutics Inc (CTNM) Awesome Oscillator (AO) is -4.695, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) Momentum (MOM) is -4.190, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) Moving Average Convergence Divergence (MACD) is -1.674, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 7.884 | Buy |
| MA_10 | 9.110 | Sell |
| MA_20 | 10.901 | Sell |
| MA_60 | 13.860 | Sell |
| MA_200 | 13.593 | Sell |
| MA_250 | 13.141 | Sell |
Contineum Therapeutics Inc (CTNM) 5-Day simple moving average is 7.884, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 10-Day simple moving average is 9.110, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Sell.
Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 10.901, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Sell.
Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 13.860, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Sell.
Contineum Therapeutics Inc (CTNM) 200-Day simple moving average is 13.593, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Sell.
Contineum Therapeutics Inc (CTNM) 250-Day simple moving average is 13.141, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.